Halper Sadeh LLC Investigates Fairness of Deals for FBRX, LXFR, SMTI, MKTX

GlobeNewswire··US·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Forte Biosciences, Luxfer Holdings, Sanara MedTech, and MarketAxess Holdings are fair to shareholders. The firm is examining Forte Biosciences' sale to argenx for $77.00 per share in cash, Luxfer Holdings' sale to affiliates of Wynnchurch Capital for $17.37 per ordinary share in cash, Sanara MedTech's sale to MiMedx Group for $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share, and MarketAxess Holdings' sale to Intercontinental Exchange for $167.00 per share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm to discuss their legal rights and options at no cost.

Impact on assets 4

Biotech & Genomic Medicine▲ · 1 stocks
Aerospace & Aviation▲ · 1 stocks
Financials▲ · 1 stocks
Aging Population▲ · 1 stocks
© 2026 MarketIVNews